HEADER IMMUNE SYSTEM 27-OCT-06 2J8U TITLE LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. CAVEAT 2J8U GLU L 57 C-ALPHA IS PLANAR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 3 CHAIN: A, H; COMPND 4 FRAGMENT: ECTO-DOMAIN, RESIDUES 25-299; COMPND 5 SYNONYM: MHC CLASS I ANTIGEN A*2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: MUTATION OF HLA-A2.1 AT POSITION 66 LYSINE TO ALANINE; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 11 CHAIN: B, I; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: HAS EXTRA METHIONINE DUE TO E. COLI EXPRESSION; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: SELF-PEPTIDE P1049; COMPND 16 CHAIN: C, J; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: SELF-PEPTIDE RECOGNIZED BY AHIII T CELL CLONE WHEN COMPND 19 PRESENTED BY HLA-A2.1; COMPND 20 MOL_ID: 4; COMPND 21 MOLECULE: AHIII TCR ALPHA CHAIN; COMPND 22 CHAIN: E, L; COMPND 23 FRAGMENT: ECTODOMAIN; COMPND 24 ENGINEERED: YES; COMPND 25 MOL_ID: 5; COMPND 26 MOLECULE: AHIII TCR BETA CHAIN; COMPND 27 CHAIN: F, M; COMPND 28 FRAGMENT: ECTODOMAIN; COMPND 29 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-A, HLAA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 16 EXPRESSION_SYSTEM_VARIANT: RIP; SOURCE 17 EXPRESSION_SYSTEM_VECTOR: PHN1; SOURCE 18 MOL_ID: 3; SOURCE 19 SYNTHETIC: YES; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 MOL_ID: 4; SOURCE 24 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 25 ORGANISM_COMMON: MOUSE; SOURCE 26 ORGANISM_TAXID: 10090; SOURCE 27 STRAIN: B6; SOURCE 28 CELL_LINE: AHIII 12.2 T CELL CLONE; SOURCE 29 CELL: T CELL; SOURCE 30 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 31 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 32 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 33 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 34 EXPRESSION_SYSTEM_VECTOR: PLM1; SOURCE 35 MOL_ID: 5; SOURCE 36 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 37 ORGANISM_COMMON: MOUSE; SOURCE 38 ORGANISM_TAXID: 10090; SOURCE 39 STRAIN: B6; SOURCE 40 CELL_LINE: AHIII 12.2 T CELL CLONE; SOURCE 41 CELL: T CELL; SOURCE 42 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 43 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 44 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 45 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 46 EXPRESSION_SYSTEM_VECTOR: PLM1 KEYWDS GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, KEYWDS 2 SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, KEYWDS 3 PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, KEYWDS 4 IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL EXPDTA X-RAY DIFFRACTION AUTHOR P.J.MILLER,Y.P.BENHAR,W.BIDDISON,E.J.COLLINS REVDAT 6 13-DEC-23 2J8U 1 REMARK REVDAT 5 12-DEC-18 2J8U 1 COMPND SOURCE JRNL REMARK REVDAT 5 2 1 DBREF SEQADV REVDAT 4 03-AUG-11 2J8U 1 COMPND SOURCE REMARK REVDAT 3 13-JUL-11 2J8U 1 VERSN REVDAT 2 24-FEB-09 2J8U 1 VERSN REVDAT 1 16-OCT-07 2J8U 0 JRNL AUTH P.J.MILLER,Y.PAZY,B.CONTI,D.RIDDLE,E.APPELLA,E.J.COLLINS JRNL TITL SINGLE MHC MUTATION ELIMINATES ENTHALPY ASSOCIATED WITH T JRNL TITL 2 CELL RECEPTOR BINDING. JRNL REF J. MOL. BIOL. V. 373 315 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17825839 JRNL DOI 10.1016/J.JMB.2007.07.028 REMARK 2 REMARK 2 RESOLUTION. 2.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 122.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 38683 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.269 REMARK 3 R VALUE (WORKING SET) : 0.268 REMARK 3 FREE R VALUE : 0.293 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.88 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.96 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1750 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3660 REMARK 3 BIN FREE R VALUE SET COUNT : 83 REMARK 3 BIN FREE R VALUE : 0.4030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 13128 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.99000 REMARK 3 B22 (A**2) : 1.02000 REMARK 3 B33 (A**2) : -1.96000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.68000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.506 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.460 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 52.965 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.906 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.872 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 13331 ; 0.005 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 18117 ; 0.750 ; 1.929 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1597 ; 4.107 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 660 ;31.089 ;23.667 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 2138 ;12.391 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 82 ; 8.199 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1906 ; 0.049 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10356 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4767 ; 0.137 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 8777 ; 0.288 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 341 ; 0.080 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 109 ; 0.104 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.091 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 8351 ; 0.057 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 12959 ; 0.104 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 5913 ; 0.080 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 5158 ; 0.137 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 14 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 183 REMARK 3 ORIGIN FOR THE GROUP (A): 15.9640 -1.3530 20.2770 REMARK 3 T TENSOR REMARK 3 T11: -0.1282 T22: -0.0353 REMARK 3 T33: -0.1256 T12: 0.0122 REMARK 3 T13: 0.0175 T23: 0.0408 REMARK 3 L TENSOR REMARK 3 L11: 3.1043 L22: 4.0267 REMARK 3 L33: 3.2714 L12: 0.7729 REMARK 3 L13: 0.5470 L23: 0.8850 REMARK 3 S TENSOR REMARK 3 S11: 0.0384 S12: -0.0145 S13: -0.0036 REMARK 3 S21: -0.0606 S22: 0.0230 S23: 0.0088 REMARK 3 S31: 0.0942 S32: -0.0739 S33: -0.0614 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 184 A 275 REMARK 3 ORIGIN FOR THE GROUP (A): 12.6170 -2.3000 54.8520 REMARK 3 T TENSOR REMARK 3 T11: 0.1773 T22: 0.2777 REMARK 3 T33: 0.1079 T12: 0.0708 REMARK 3 T13: -0.0376 T23: -0.0293 REMARK 3 L TENSOR REMARK 3 L11: 2.4277 L22: 6.3290 REMARK 3 L33: 9.0772 L12: 0.4187 REMARK 3 L13: 0.5371 L23: -5.4815 REMARK 3 S TENSOR REMARK 3 S11: 0.1368 S12: -0.4338 S13: -0.3994 REMARK 3 S21: 0.1112 S22: -0.0596 S23: 0.0260 REMARK 3 S31: 0.4333 S32: -0.3573 S33: -0.0772 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 99 REMARK 3 ORIGIN FOR THE GROUP (A): -1.0720 5.9620 39.2050 REMARK 3 T TENSOR REMARK 3 T11: -0.0779 T22: 0.4606 REMARK 3 T33: -0.0074 T12: 0.0021 REMARK 3 T13: -0.0706 T23: 0.1412 REMARK 3 L TENSOR REMARK 3 L11: 4.8698 L22: 7.2033 REMARK 3 L33: 7.8681 L12: -2.2984 REMARK 3 L13: -2.3242 L23: 6.1847 REMARK 3 S TENSOR REMARK 3 S11: -0.1478 S12: 0.0971 S13: 0.0088 REMARK 3 S21: 0.3904 S22: -0.1163 S23: 0.6027 REMARK 3 S31: 0.3410 S32: -0.7145 S33: 0.2642 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 0 E 116 REMARK 3 ORIGIN FOR THE GROUP (A): 35.6480 -5.9110 -5.6560 REMARK 3 T TENSOR REMARK 3 T11: -0.0985 T22: 0.0185 REMARK 3 T33: -0.0361 T12: -0.0905 REMARK 3 T13: -0.0677 T23: 0.0371 REMARK 3 L TENSOR REMARK 3 L11: 8.3043 L22: 2.6295 REMARK 3 L33: 8.7473 L12: -1.9663 REMARK 3 L13: -3.0830 L23: 0.3054 REMARK 3 S TENSOR REMARK 3 S11: -0.0823 S12: -0.3858 S13: -0.0821 REMARK 3 S21: 0.3355 S22: 0.0307 S23: 0.1177 REMARK 3 S31: -0.3275 S32: 0.2045 S33: 0.0517 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 117 E 198 REMARK 3 ORIGIN FOR THE GROUP (A): 44.2300 -1.1570 -38.3400 REMARK 3 T TENSOR REMARK 3 T11: -0.1613 T22: 0.6318 REMARK 3 T33: 0.0587 T12: 0.0266 REMARK 3 T13: -0.0496 T23: -0.0589 REMARK 3 L TENSOR REMARK 3 L11: 11.6346 L22: 9.9241 REMARK 3 L33: 11.2578 L12: -3.0377 REMARK 3 L13: 1.2357 L23: -2.6253 REMARK 3 S TENSOR REMARK 3 S11: -0.0001 S12: 0.8774 S13: 0.3737 REMARK 3 S21: -0.2908 S22: -0.1824 S23: -0.4556 REMARK 3 S31: -0.6406 S32: -0.0600 S33: 0.1826 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 1 F 117 REMARK 3 ORIGIN FOR THE GROUP (A): 17.6210 6.3040 -9.4160 REMARK 3 T TENSOR REMARK 3 T11: -0.0984 T22: 0.2268 REMARK 3 T33: -0.0584 T12: 0.1388 REMARK 3 T13: -0.0958 T23: -0.0530 REMARK 3 L TENSOR REMARK 3 L11: 2.9451 L22: 8.1134 REMARK 3 L33: 8.6681 L12: 0.0853 REMARK 3 L13: -0.2295 L23: -4.8502 REMARK 3 S TENSOR REMARK 3 S11: -0.0371 S12: 0.1639 S13: 0.1031 REMARK 3 S21: 0.2776 S22: 0.2083 S23: 0.0663 REMARK 3 S31: -0.6055 S32: -0.4405 S33: -0.1713 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 118 F 245 REMARK 3 ORIGIN FOR THE GROUP (A): 27.4210 1.3580 -39.3040 REMARK 3 T TENSOR REMARK 3 T11: -0.1915 T22: 0.5564 REMARK 3 T33: 0.1716 T12: -0.0541 REMARK 3 T13: -0.1927 T23: 0.0218 REMARK 3 L TENSOR REMARK 3 L11: 2.8077 L22: 7.1254 REMARK 3 L33: 5.3697 L12: -2.3496 REMARK 3 L13: -0.3677 L23: 2.7846 REMARK 3 S TENSOR REMARK 3 S11: 0.1193 S12: 0.3869 S13: -0.0487 REMARK 3 S21: -0.1205 S22: -0.2096 S23: 0.5259 REMARK 3 S31: -0.1881 S32: 0.2009 S33: 0.0902 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 1 H 183 REMARK 3 ORIGIN FOR THE GROUP (A): 16.1370 41.0090 25.1980 REMARK 3 T TENSOR REMARK 3 T11: -0.1119 T22: -0.0584 REMARK 3 T33: -0.1092 T12: 0.0030 REMARK 3 T13: 0.0371 T23: 0.0328 REMARK 3 L TENSOR REMARK 3 L11: 4.0897 L22: 3.8048 REMARK 3 L33: 4.7167 L12: 0.8468 REMARK 3 L13: 0.3232 L23: 0.6460 REMARK 3 S TENSOR REMARK 3 S11: -0.0590 S12: -0.0052 S13: -0.0238 REMARK 3 S21: -0.0675 S22: -0.0038 S23: 0.0710 REMARK 3 S31: 0.4196 S32: -0.1804 S33: 0.0629 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 184 H 275 REMARK 3 ORIGIN FOR THE GROUP (A): 13.1560 39.7750 59.8810 REMARK 3 T TENSOR REMARK 3 T11: -0.0010 T22: 0.2453 REMARK 3 T33: 0.0348 T12: 0.0132 REMARK 3 T13: -0.1343 T23: -0.0669 REMARK 3 L TENSOR REMARK 3 L11: 2.1881 L22: 6.9380 REMARK 3 L33: 13.5915 L12: 0.6332 REMARK 3 L13: -0.3896 L23: -7.7300 REMARK 3 S TENSOR REMARK 3 S11: 0.1490 S12: -0.2917 S13: -0.3048 REMARK 3 S21: 0.1639 S22: 0.0482 S23: -0.0270 REMARK 3 S31: 0.4647 S32: -0.3701 S33: -0.1972 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : I 0 I 99 REMARK 3 ORIGIN FOR THE GROUP (A): -0.7310 48.4830 44.3160 REMARK 3 T TENSOR REMARK 3 T11: -0.2236 T22: 0.3363 REMARK 3 T33: -0.0167 T12: 0.0289 REMARK 3 T13: -0.0791 T23: 0.1397 REMARK 3 L TENSOR REMARK 3 L11: 4.2262 L22: 5.7904 REMARK 3 L33: 9.6399 L12: -0.8213 REMARK 3 L13: -2.6813 L23: 4.1620 REMARK 3 S TENSOR REMARK 3 S11: -0.0627 S12: 0.2253 S13: 0.1952 REMARK 3 S21: 0.1675 S22: 0.0163 S23: 0.5233 REMARK 3 S31: 0.0026 S32: -0.5597 S33: 0.0465 REMARK 3 REMARK 3 TLS GROUP : 11 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 0 L 116 REMARK 3 ORIGIN FOR THE GROUP (A): 35.8820 36.2090 -0.7230 REMARK 3 T TENSOR REMARK 3 T11: -0.1328 T22: 0.0245 REMARK 3 T33: -0.0215 T12: -0.0350 REMARK 3 T13: -0.0788 T23: 0.0428 REMARK 3 L TENSOR REMARK 3 L11: 8.9221 L22: 2.5900 REMARK 3 L33: 8.2584 L12: -0.5706 REMARK 3 L13: -3.9478 L23: 0.3903 REMARK 3 S TENSOR REMARK 3 S11: -0.1055 S12: -0.1264 S13: -0.0960 REMARK 3 S21: 0.2672 S22: -0.0330 S23: 0.1640 REMARK 3 S31: -0.1973 S32: 0.0682 S33: 0.1386 REMARK 3 REMARK 3 TLS GROUP : 12 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 117 L 198 REMARK 3 ORIGIN FOR THE GROUP (A): 44.8100 41.8110 -33.2590 REMARK 3 T TENSOR REMARK 3 T11: -0.1202 T22: 0.5221 REMARK 3 T33: 0.0159 T12: 0.0091 REMARK 3 T13: -0.0149 T23: -0.0204 REMARK 3 L TENSOR REMARK 3 L11: 10.0494 L22: 12.6809 REMARK 3 L33: 13.5798 L12: -4.2284 REMARK 3 L13: 1.1100 L23: -2.6391 REMARK 3 S TENSOR REMARK 3 S11: 0.1993 S12: 0.2025 S13: 0.5405 REMARK 3 S21: -0.8267 S22: -0.2485 S23: -0.8090 REMARK 3 S31: -0.7308 S32: 0.6466 S33: 0.0492 REMARK 3 REMARK 3 TLS GROUP : 13 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : M 1 M 117 REMARK 3 ORIGIN FOR THE GROUP (A): 18.0490 48.6540 -4.4380 REMARK 3 T TENSOR REMARK 3 T11: -0.1485 T22: 0.3220 REMARK 3 T33: -0.0278 T12: 0.1240 REMARK 3 T13: -0.1025 T23: -0.0330 REMARK 3 L TENSOR REMARK 3 L11: 2.2580 L22: 7.8781 REMARK 3 L33: 8.3661 L12: 0.0843 REMARK 3 L13: -0.2409 L23: -4.9083 REMARK 3 S TENSOR REMARK 3 S11: -0.0528 S12: 0.0392 S13: 0.1077 REMARK 3 S21: 0.1408 S22: 0.3182 S23: 0.0801 REMARK 3 S31: -0.4963 S32: -0.9367 S33: -0.2655 REMARK 3 REMARK 3 TLS GROUP : 14 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : M 118 M 245 REMARK 3 ORIGIN FOR THE GROUP (A): 28.0580 44.2400 -34.2280 REMARK 3 T TENSOR REMARK 3 T11: -0.0897 T22: 0.4677 REMARK 3 T33: 0.0890 T12: -0.0004 REMARK 3 T13: -0.2181 T23: 0.0281 REMARK 3 L TENSOR REMARK 3 L11: 3.1671 L22: 7.3371 REMARK 3 L33: 5.2352 L12: -2.6080 REMARK 3 L13: -0.9561 L23: 1.9343 REMARK 3 S TENSOR REMARK 3 S11: 0.3263 S12: 0.4180 S13: 0.0724 REMARK 3 S21: -0.2162 S22: -0.2194 S23: 0.4642 REMARK 3 S31: -0.3434 S32: 0.1179 S33: -0.1069 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES IN THE TCR ALPHA CHAINS E AND L 50- 59 ARE REMARK 3 COMPLETELY DISORDERED IN THE STRUCTURE AND THUS THE COORDINATES REMARK 3 HAVE AN OCCUPANCY OF 0.0 REMARK 4 REMARK 4 2J8U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1290030313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38683 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.880 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.8 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1LP9 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M NACL 20% PEG 8000 MES, PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.94650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 10840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, J, L, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 90 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN H, LYS 90 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET F 0 REMARK 465 MET M 0 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU F 1 CG CD OE1 OE2 REMARK 470 GLU M 1 CG CD OE1 OE2 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 THR E 51 REMARK 475 ASP E 52 REMARK 475 ASN E 53 REMARK 475 LYS E 54 REMARK 475 ARG E 55 REMARK 475 PRO E 56 REMARK 475 GLU E 57 REMARK 475 HIS E 58 REMARK 475 GLN E 59 REMARK 475 THR E 198 REMARK 475 THR L 51 REMARK 475 ASP L 52 REMARK 475 ASN L 53 REMARK 475 LYS L 54 REMARK 475 ARG L 55 REMARK 475 PRO L 56 REMARK 475 GLU L 57 REMARK 475 HIS L 58 REMARK 475 GLN L 59 REMARK 475 THR L 198 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE L 50 CG2 THR L 51 1.26 REMARK 500 CB LYS L 54 O LEU L 66 1.56 REMARK 500 C GLN L 59 CA GLY L 61 1.63 REMARK 500 O LYS L 54 N LEU L 66 1.89 REMARK 500 OE2 GLU L 57 O ALA L 64 1.89 REMARK 500 O LYS E 48 CB PRO E 56 1.92 REMARK 500 N PHE L 50 CG PRO L 56 1.96 REMARK 500 O GLN E 59 N PHE E 62 2.02 REMARK 500 CD PRO E 56 O ALA E 64 2.13 REMARK 500 NZ LYS L 54 CE LYS L 68 2.14 REMARK 500 O LYS L 54 CA THR L 65 2.18 REMARK 500 NZ LYS L 54 NZ LYS L 68 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O THR E 198 NH2 ARG H 169 2645 1.71 REMARK 500 NE2 GLN E 59 CD1 LEU M 84 1545 1.79 REMARK 500 OG1 THR E 198 NE ARG H 108 2645 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU E 197 C THR E 198 N 0.199 REMARK 500 PRO L 56 CG PRO L 56 CD -0.485 REMARK 500 GLU L 57 N GLU L 57 CA 0.136 REMARK 500 HIS L 58 N HIS L 58 CA 0.142 REMARK 500 HIS L 58 CA HIS L 58 C 0.157 REMARK 500 GLN L 59 CA GLN L 59 CB 0.405 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO E 56 CA - N - CD ANGL. DEV. = -12.9 DEGREES REMARK 500 HIS E 58 CB - CA - C ANGL. DEV. = 12.3 DEGREES REMARK 500 ASP L 52 CA - C - N ANGL. DEV. = -21.2 DEGREES REMARK 500 ASP L 52 O - C - N ANGL. DEV. = 10.7 DEGREES REMARK 500 LYS L 54 C - N - CA ANGL. DEV. = -17.4 DEGREES REMARK 500 LYS L 54 CB - CA - C ANGL. DEV. = 13.0 DEGREES REMARK 500 PRO L 56 N - CA - CB ANGL. DEV. = -17.6 DEGREES REMARK 500 PRO L 56 N - CD - CG ANGL. DEV. = 11.4 DEGREES REMARK 500 PRO L 56 N - CA - C ANGL. DEV. = 17.4 DEGREES REMARK 500 GLU L 57 N - CA - CB ANGL. DEV. = -15.1 DEGREES REMARK 500 GLU L 57 N - CA - C ANGL. DEV. = 31.2 DEGREES REMARK 500 GLU L 57 CA - C - N ANGL. DEV. = 13.2 DEGREES REMARK 500 GLU L 57 O - C - N ANGL. DEV. = -22.9 DEGREES REMARK 500 HIS L 58 CA - CB - CG ANGL. DEV. = 18.7 DEGREES REMARK 500 HIS L 58 N - CA - C ANGL. DEV. = 24.5 DEGREES REMARK 500 GLN L 59 CB - CA - C ANGL. DEV. = -17.0 DEGREES REMARK 500 GLN L 59 N - CA - CB ANGL. DEV. = 25.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -109.21 60.78 REMARK 500 HIS A 114 103.72 -164.10 REMARK 500 TYR A 123 -76.32 -121.00 REMARK 500 SER E 29 103.30 -52.11 REMARK 500 ASN E 53 70.22 -30.75 REMARK 500 LYS E 54 -34.37 98.05 REMARK 500 GLU E 57 140.39 122.53 REMARK 500 SER E 85 97.47 -59.83 REMARK 500 SER E 98 89.75 -154.70 REMARK 500 ALA E 172 -94.70 -70.81 REMARK 500 SER E 175 51.72 -90.94 REMARK 500 PHE E 195 32.98 -94.30 REMARK 500 GLU E 197 99.33 73.22 REMARK 500 ILE F 46 -61.41 -101.28 REMARK 500 ASP F 96 -153.37 -90.08 REMARK 500 PRO F 154 127.04 3.79 REMARK 500 ASP F 155 35.59 -73.29 REMARK 500 ASP H 29 -103.59 59.50 REMARK 500 HIS H 114 100.34 -164.62 REMARK 500 TYR H 123 -76.07 -113.63 REMARK 500 SER L 49 79.59 -105.47 REMARK 500 ASP L 52 130.35 75.83 REMARK 500 ASN L 53 -124.19 51.52 REMARK 500 PRO L 56 -87.62 -71.93 REMARK 500 GLU L 57 -138.60 83.11 REMARK 500 PHE L 73 67.75 -151.59 REMARK 500 LEU L 96 104.05 -55.78 REMARK 500 SER L 99 -162.40 173.22 REMARK 500 MET L 170 95.60 -67.86 REMARK 500 ALA L 172 97.23 -47.07 REMARK 500 MET L 173 76.41 47.70 REMARK 500 ASP L 174 75.18 35.05 REMARK 500 GLN L 186 82.89 -65.48 REMARK 500 THR L 187 -106.54 25.34 REMARK 500 ASP M 96 -156.01 -82.88 REMARK 500 ASP M 155 54.71 -91.87 REMARK 500 HIS M 156 38.90 -98.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE F 153 PRO F 154 -127.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU E 197 13.44 REMARK 500 GLU L 57 -26.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 1N2R RELATED DB: PDB REMARK 900 A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF,PEPTIDE REMARK 900 REPORTOIRE AND T CELL RECOGNITION. REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 2V2W RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 2BSU RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND- REMARK 900 C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND REMARK 900 TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT. REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271- REMARK 900 279) REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B* 3501 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE ( RESIDUES 412-420) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2BSV RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND REMARK 900 LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2VB5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTANT K66A REMARK 999 ADDITIONAL METHIONINE AT N TERMINUS DUE TO EXPRESSION IN E. REMARK 999 COLI DBREF 2J8U A 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2J8U B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2J8U C 1 9 PDB 2J8U 2J8U 1 9 DBREF 2J8U E 0 198 PDB 2J8U 2J8U 0 198 DBREF 2J8U F 0 245 PDB 2J8U 2J8U 0 245 DBREF 2J8U H 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2J8U I 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2J8U J 1 9 PDB 2J8U 2J8U 1 9 DBREF 2J8U L 0 198 PDB 2J8U 2J8U 0 198 DBREF 2J8U M 0 245 PDB 2J8U 2J8U 0 245 SEQADV 2J8U ALA A 66 UNP P01892 LYS 90 ENGINEERED MUTATION SEQADV 2J8U MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 2J8U ALA H 66 UNP P01892 LYS 90 ENGINEERED MUTATION SEQADV 2J8U MET I 0 UNP P61769 INITIATING METHIONINE SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 275 ALA VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 ALA LEU TRP GLY PHE PHE PRO VAL LEU SEQRES 1 E 194 MET ASP SER VAL THR GLN THR GLU GLY LEU VAL THR LEU SEQRES 2 E 194 THR GLU GLY LEU PRO VAL MET LEU ASN CYS THR TYR GLN SEQRES 3 E 194 SER THR TYR SER PRO PHE LEU PHE TRP TYR VAL GLN HIS SEQRES 4 E 194 LEU ASN GLU ALA PRO LYS LEU LEU LEU LYS SER PHE THR SEQRES 5 E 194 ASP ASN LYS ARG PRO GLU HIS GLN GLY PHE HIS ALA THR SEQRES 6 E 194 LEU HIS LYS SER SER SER SER PHE HIS LEU GLN LYS SER SEQRES 7 E 194 SER ALA GLN LEU SER ASP SER ALA LEU TYR TYR CYS ALA SEQRES 8 E 194 LEU PHE LEU ALA SER SER SER PHE SER LYS LEU VAL PHE SEQRES 9 E 194 GLY GLN GLY THR SER LEU SER VAL VAL PRO ASN ILE GLN SEQRES 10 E 194 ASN PRO GLU PRO ALA VAL TYR GLN LEU LYS ASP PRO ARG SEQRES 11 E 194 SER GLN ASP SER THR LEU CYS LEU PHE THR ASP PHE ASP SEQRES 12 E 194 SER GLN ILE ASN VAL PRO LYS THR MET GLU SER GLY THR SEQRES 13 E 194 PHE ILE THR ASP LYS THR VAL LEU ASP MET LYS ALA MET SEQRES 14 E 194 ASP SER LYS SER ASN GLY ALA ILE ALA TRP SER ASN GLN SEQRES 15 E 194 THR SER PHE THR CYS GLN ASP ILE PHE LYS GLU THR SEQRES 1 F 238 MET GLU ALA ALA VAL THR GLN SER PRO ARG SER LYS VAL SEQRES 2 F 238 ALA VAL THR GLY GLY LYS VAL THR LEU SER CYS HIS GLN SEQRES 3 F 238 THR ASN ASN HIS ASP TYR MET TYR TRP TYR ARG GLN ASP SEQRES 4 F 238 THR GLY HIS GLY LEU ARG LEU ILE HIS TYR SER TYR VAL SEQRES 5 F 238 ALA ASP SER THR GLU LYS GLY ASP ILE PRO ASP GLY TYR SEQRES 6 F 238 LYS ALA SER ARG PRO SER GLN GLU ASN PHE SER LEU ILE SEQRES 7 F 238 LEU GLU LEU ALA SER LEU SER GLN THR ALA VAL TYR PHE SEQRES 8 F 238 CYS ALA SER SER ASP TRP VAL SER TYR GLU GLN TYR PHE SEQRES 9 F 238 GLY PRO GLY THR ARG LEU THR VAL LEU GLU ASP LEU ARG SEQRES 10 F 238 ASN VAL THR PRO PRO LYS VAL SER LEU PHE GLU PRO SER SEQRES 11 F 238 LYS ALA GLU ILE ALA ASN LYS GLN LYS ALA THR LEU VAL SEQRES 12 F 238 CYS LEU ALA ARG GLY PHE PHE PRO ASP HIS VAL GLU LEU SEQRES 13 F 238 SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL SEQRES 14 F 238 SER THR ASP PRO GLN ALA TYR LYS GLU SER ASN TYR SER SEQRES 15 F 238 TYR ALA LEU SER SER ARG LEU ARG VAL SER ALA THR PHE SEQRES 16 F 238 TRP HIS ASN PRO ARG ASN HIS PHE ARG CYS GLN VAL GLN SEQRES 17 F 238 PHE HIS GLY LEU SER GLU GLU ASP LYS TRP PRO GLU GLY SEQRES 18 F 238 SER PRO LYS PRO VAL THR GLN ASN ILE SER ALA GLU ALA SEQRES 19 F 238 TRP GLY ARG ALA SEQRES 1 H 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 H 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 H 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 H 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 H 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 H 275 ALA VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 H 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 H 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 H 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 H 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 H 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 H 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 H 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 H 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 H 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 H 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 H 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 H 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 H 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 H 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 H 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 H 275 TRP GLU SEQRES 1 I 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 I 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 I 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 I 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 I 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 I 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 I 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 I 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 J 9 ALA LEU TRP GLY PHE PHE PRO VAL LEU SEQRES 1 L 194 MET ASP SER VAL THR GLN THR GLU GLY LEU VAL THR LEU SEQRES 2 L 194 THR GLU GLY LEU PRO VAL MET LEU ASN CYS THR TYR GLN SEQRES 3 L 194 SER THR TYR SER PRO PHE LEU PHE TRP TYR VAL GLN HIS SEQRES 4 L 194 LEU ASN GLU ALA PRO LYS LEU LEU LEU LYS SER PHE THR SEQRES 5 L 194 ASP ASN LYS ARG PRO GLU HIS GLN GLY PHE HIS ALA THR SEQRES 6 L 194 LEU HIS LYS SER SER SER SER PHE HIS LEU GLN LYS SER SEQRES 7 L 194 SER ALA GLN LEU SER ASP SER ALA LEU TYR TYR CYS ALA SEQRES 8 L 194 LEU PHE LEU ALA SER SER SER PHE SER LYS LEU VAL PHE SEQRES 9 L 194 GLY GLN GLY THR SER LEU SER VAL VAL PRO ASN ILE GLN SEQRES 10 L 194 ASN PRO GLU PRO ALA VAL TYR GLN LEU LYS ASP PRO ARG SEQRES 11 L 194 SER GLN ASP SER THR LEU CYS LEU PHE THR ASP PHE ASP SEQRES 12 L 194 SER GLN ILE ASN VAL PRO LYS THR MET GLU SER GLY THR SEQRES 13 L 194 PHE ILE THR ASP LYS THR VAL LEU ASP MET LYS ALA MET SEQRES 14 L 194 ASP SER LYS SER ASN GLY ALA ILE ALA TRP SER ASN GLN SEQRES 15 L 194 THR SER PHE THR CYS GLN ASP ILE PHE LYS GLU THR SEQRES 1 M 238 MET GLU ALA ALA VAL THR GLN SER PRO ARG SER LYS VAL SEQRES 2 M 238 ALA VAL THR GLY GLY LYS VAL THR LEU SER CYS HIS GLN SEQRES 3 M 238 THR ASN ASN HIS ASP TYR MET TYR TRP TYR ARG GLN ASP SEQRES 4 M 238 THR GLY HIS GLY LEU ARG LEU ILE HIS TYR SER TYR VAL SEQRES 5 M 238 ALA ASP SER THR GLU LYS GLY ASP ILE PRO ASP GLY TYR SEQRES 6 M 238 LYS ALA SER ARG PRO SER GLN GLU ASN PHE SER LEU ILE SEQRES 7 M 238 LEU GLU LEU ALA SER LEU SER GLN THR ALA VAL TYR PHE SEQRES 8 M 238 CYS ALA SER SER ASP TRP VAL SER TYR GLU GLN TYR PHE SEQRES 9 M 238 GLY PRO GLY THR ARG LEU THR VAL LEU GLU ASP LEU ARG SEQRES 10 M 238 ASN VAL THR PRO PRO LYS VAL SER LEU PHE GLU PRO SER SEQRES 11 M 238 LYS ALA GLU ILE ALA ASN LYS GLN LYS ALA THR LEU VAL SEQRES 12 M 238 CYS LEU ALA ARG GLY PHE PHE PRO ASP HIS VAL GLU LEU SEQRES 13 M 238 SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL SEQRES 14 M 238 SER THR ASP PRO GLN ALA TYR LYS GLU SER ASN TYR SER SEQRES 15 M 238 TYR ALA LEU SER SER ARG LEU ARG VAL SER ALA THR PHE SEQRES 16 M 238 TRP HIS ASN PRO ARG ASN HIS PHE ARG CYS GLN VAL GLN SEQRES 17 M 238 PHE HIS GLY LEU SER GLU GLU ASP LYS TRP PRO GLU GLY SEQRES 18 M 238 SER PRO LYS PRO VAL THR GLN ASN ILE SER ALA GLU ALA SEQRES 19 M 238 TRP GLY ARG ALA HELIX 1 1 PRO A 50 GLU A 55 5 6 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLU A 161 1 11 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLN A 253 GLN A 255 5 3 HELIX 8 8 GLN E 81 SER E 85 5 5 HELIX 9 9 THR E 190 PHE E 195 1 6 HELIX 10 10 SER F 83 THR F 87 5 5 HELIX 11 11 SER F 133 GLN F 141 1 9 HELIX 12 12 ALA F 200 HIS F 204 1 5 HELIX 13 13 ALA H 49 GLU H 53 5 5 HELIX 14 14 GLY H 56 TYR H 85 1 30 HELIX 15 15 ASP H 137 ALA H 150 1 14 HELIX 16 16 HIS H 151 GLY H 162 1 12 HELIX 17 17 GLY H 162 GLY H 175 1 14 HELIX 18 18 GLY H 175 GLN H 180 1 6 HELIX 19 19 GLN H 253 GLN H 255 5 3 HELIX 20 20 GLN L 81 SER L 85 5 5 HELIX 21 21 THR L 190 ILE L 194 5 5 HELIX 22 22 SER M 83 THR M 87 5 5 HELIX 23 23 ASP M 118 VAL M 122 5 5 HELIX 24 24 SER M 133 GLN M 141 1 9 HELIX 25 25 ALA M 200 ASN M 205 1 6 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 THR A 228 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242 SHEET 1 AD 4 GLU A 222 GLN A 224 0 SHEET 2 AD 4 THR A 214 ARG A 219 -1 O TRP A 217 N GLN A 224 SHEET 3 AD 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 AD 4 LEU A 270 LEU A 272 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N GLY B 29 SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N GLY B 29 SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 BC 4 GLU B 44 ARG B 45 0 SHEET 2 BC 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BC 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 EA 2 SER E 2 GLN E 5 0 SHEET 2 EA 2 CYS E 22 GLN E 25 -1 O THR E 23 N THR E 4 SHEET 1 EB 5 LEU E 9 THR E 13 0 SHEET 2 EB 5 THR E 110 VAL E 115 1 O SER E 111 N VAL E 10 SHEET 3 EB 5 ALA E 86 PHE E 93 -1 O ALA E 86 N LEU E 112 SHEET 4 EB 5 PHE E 31 GLN E 37 -1 O PHE E 31 N PHE E 93 SHEET 5 EB 5 LYS E 44 LYS E 48 -1 O LYS E 44 N VAL E 36 SHEET 1 EC 4 LEU E 9 THR E 13 0 SHEET 2 EC 4 THR E 110 VAL E 115 1 O SER E 111 N VAL E 10 SHEET 3 EC 4 ALA E 86 PHE E 93 -1 O ALA E 86 N LEU E 112 SHEET 4 EC 4 LEU E 104 PHE E 106 -1 O VAL E 105 N LEU E 92 SHEET 1 ED 3 VAL E 18 LEU E 20 0 SHEET 2 ED 3 LEU E 75 LYS E 77 -1 O LEU E 75 N LEU E 20 SHEET 3 ED 3 HIS E 63 ALA E 64 -1 O HIS E 63 N GLN E 76 SHEET 1 EE 7 ALA E 124 LYS E 129 0 SHEET 2 EE 7 THR E 139 THR E 144 -1 O LEU E 140 N LEU E 128 SHEET 3 EE 7 SER E 177 TRP E 183 -1 O ALA E 180 N PHE E 143 SHEET 4 EE 7 PHE E 161 ILE E 162 -1 O PHE E 161 N TRP E 183 SHEET 5 EE 7 SER E 177 TRP E 183 -1 O TRP E 183 N PHE E 161 SHEET 6 EE 7 THR E 166 LEU E 168 -1 O THR E 166 N GLY E 179 SHEET 7 EE 7 SER E 177 TRP E 183 -1 O SER E 177 N LEU E 168 SHEET 1 FA 4 VAL F 4 SER F 7 0 SHEET 2 FA 4 VAL F 19 GLN F 25 -1 O SER F 22 N SER F 7 SHEET 3 FA 4 SER F 76 LEU F 79 -1 O LEU F 77 N LEU F 21 SHEET 4 FA 4 LYS F 66 SER F 68 -1 O LYS F 66 N ILE F 78 SHEET 1 FB 9 SER F 10 VAL F 14 0 SHEET 2 FB 9 THR F 112 LEU F 116A 1 O ARG F 113 N LYS F 11 SHEET 3 FB 9 ALA F 88 SER F 95 -1 O ALA F 88 N LEU F 114 SHEET 4 FB 9 SER F 54 LYS F 57 0 SHEET 5 FB 9 HIS F 41 VAL F 51 -1 O TYR F 48 N GLU F 56 SHEET 6 FB 9 TYR F 31 ASP F 38 -1 O MET F 32 N SER F 49 SHEET 7 FB 9 ALA F 88 SER F 95 -1 O VAL F 89 N GLN F 37 SHEET 8 FB 9 TYR F 107 PHE F 108 -1 O TYR F 107 N SER F 94 SHEET 9 FB 9 ALA F 88 SER F 95 -1 O SER F 94 N TYR F 107 SHEET 1 FC 7 LYS F 126 PHE F 130 0 SHEET 2 FC 7 LYS F 142 PHE F 152 -1 O VAL F 146 N PHE F 130 SHEET 3 FC 7 SER F 189 SER F 199 -1 O TYR F 190 N PHE F 152 SHEET 4 FC 7 VAL F 172 THR F 174 -1 O SER F 173 N ARG F 195 SHEET 5 FC 7 SER F 189 SER F 199 -1 O ARG F 195 N SER F 173 SHEET 6 FC 7 TYR F 179 SER F 182 -1 O TYR F 179 N ALA F 191 SHEET 7 FC 7 SER F 189 SER F 199 -1 O SER F 189 N SER F 182 SHEET 1 FD 4 LYS F 166 VAL F 168 0 SHEET 2 FD 4 VAL F 157 VAL F 163 -1 O TRP F 161 N VAL F 168 SHEET 3 FD 4 HIS F 209 PHE F 216 -1 O ARG F 211 N TRP F 162 SHEET 4 FD 4 GLN F 235 TRP F 242 -1 O GLN F 235 N PHE F 216 SHEET 1 HA 8 GLU H 46 PRO H 47 0 SHEET 2 HA 8 THR H 31 ASP H 37 -1 O ARG H 35 N GLU H 46 SHEET 3 HA 8 ARG H 21 VAL H 28 -1 O ALA H 24 N PHE H 36 SHEET 4 HA 8 HIS H 3 VAL H 12 -1 O ARG H 6 N TYR H 27 SHEET 5 HA 8 THR H 94 VAL H 103 -1 O VAL H 95 N SER H 11 SHEET 6 HA 8 PHE H 109 TYR H 118 -1 N LEU H 110 O ASP H 102 SHEET 7 HA 8 LYS H 121 LEU H 126 -1 O LYS H 121 N TYR H 118 SHEET 8 HA 8 TRP H 133 ALA H 135 -1 O THR H 134 N ALA H 125 SHEET 1 HB 7 LYS H 186 HIS H 192 0 SHEET 2 HB 7 GLU H 198 PHE H 208 -1 O THR H 200 N HIS H 192 SHEET 3 HB 7 PHE H 241 PRO H 250 -1 O PHE H 241 N PHE H 208 SHEET 4 HB 7 THR H 228 LEU H 230 -1 O GLU H 229 N ALA H 246 SHEET 5 HB 7 PHE H 241 PRO H 250 -1 O ALA H 246 N GLU H 229 SHEET 6 HB 7 ARG H 234 PRO H 235 -1 O ARG H 234 N GLN H 242 SHEET 7 HB 7 PHE H 241 PRO H 250 -1 O GLN H 242 N ARG H 234 SHEET 1 HC 4 GLU H 222 GLN H 224 0 SHEET 2 HC 4 THR H 214 ARG H 219 -1 O TRP H 217 N GLN H 224 SHEET 3 HC 4 TYR H 257 GLN H 262 -1 O THR H 258 N GLN H 218 SHEET 4 HC 4 LEU H 270 ARG H 273 -1 O LEU H 270 N VAL H 261 SHEET 1 IA 7 LYS I 6 SER I 11 0 SHEET 2 IA 7 ASN I 21 PHE I 30 -1 O ASN I 24 N TYR I 10 SHEET 3 IA 7 PHE I 62 PHE I 70 -1 O PHE I 62 N PHE I 30 SHEET 4 IA 7 GLU I 50 HIS I 51 -1 O GLU I 50 N TYR I 67 SHEET 5 IA 7 PHE I 62 PHE I 70 -1 O TYR I 67 N GLU I 50 SHEET 6 IA 7 SER I 55 PHE I 56 -1 O SER I 55 N TYR I 63 SHEET 7 IA 7 PHE I 62 PHE I 70 -1 O TYR I 63 N SER I 55 SHEET 1 IB 4 GLU I 44 ARG I 45 0 SHEET 2 IB 4 GLU I 36 LYS I 41 -1 O LYS I 41 N GLU I 44 SHEET 3 IB 4 TYR I 78 ASN I 83 -1 O ALA I 79 N LEU I 40 SHEET 4 IB 4 LYS I 91 LYS I 94 -1 O LYS I 91 N VAL I 82 SHEET 1 LA 2 VAL L 3 GLN L 5 0 SHEET 2 LA 2 CYS L 22 TYR L 24 -1 O THR L 23 N THR L 4 SHEET 1 LB 8 LEU L 9 THR L 13 0 SHEET 2 LB 8 THR L 110 VAL L 115 1 O SER L 111 N VAL L 10 SHEET 3 LB 8 LEU L 87 PHE L 93 -1 O TYR L 88 N THR L 110 SHEET 4 LB 8 LYS L 44 LYS L 48 0 SHEET 5 LB 8 PHE L 31 GLN L 37 -1 O TRP L 34 N LEU L 46 SHEET 6 LB 8 LEU L 87 PHE L 93 -1 O LEU L 87 N GLN L 37 SHEET 7 LB 8 LEU L 104 PHE L 106 -1 O VAL L 105 N LEU L 92 SHEET 8 LB 8 LEU L 87 PHE L 93 -1 O LEU L 92 N VAL L 105 SHEET 1 LC 3 VAL L 18 LEU L 20 0 SHEET 2 LC 3 LEU L 75 LYS L 77 -1 O LEU L 75 N LEU L 20 SHEET 3 LC 3 PHE L 62 ALA L 64 -1 O HIS L 63 N GLN L 76 SHEET 1 LD 7 ALA L 124 LYS L 129 0 SHEET 2 LD 7 THR L 139 THR L 144 -1 O LEU L 140 N LEU L 128 SHEET 3 LD 7 SER L 175 TRP L 183 -1 O ALA L 180 N PHE L 143 SHEET 4 LD 7 PHE L 161 ILE L 162 -1 O PHE L 161 N TRP L 183 SHEET 5 LD 7 SER L 175 TRP L 183 -1 O TRP L 183 N PHE L 161 SHEET 6 LD 7 THR L 166 MET L 170 -1 O THR L 166 N GLY L 179 SHEET 7 LD 7 SER L 175 TRP L 183 -1 O SER L 175 N MET L 170 SHEET 1 MA 4 VAL M 4 SER M 7 0 SHEET 2 MA 4 VAL M 19 GLN M 25 -1 O SER M 22 N SER M 7 SHEET 3 MA 4 SER M 76 LEU M 79 -1 O LEU M 77 N LEU M 21 SHEET 4 MA 4 TYR M 65 SER M 68 -1 O LYS M 66 N ILE M 78 SHEET 1 MB 9 SER M 10 VAL M 14 0 SHEET 2 MB 9 THR M 112 LEU M 116A 1 O ARG M 113 N LYS M 11 SHEET 3 MB 9 ALA M 88 SER M 95 -1 O ALA M 88 N LEU M 114 SHEET 4 MB 9 SER M 54 LYS M 57 0 SHEET 5 MB 9 HIS M 41 VAL M 51 -1 O TYR M 48 N GLU M 56 SHEET 6 MB 9 TYR M 31 ASP M 38 -1 O MET M 32 N SER M 49 SHEET 7 MB 9 ALA M 88 SER M 95 -1 O VAL M 89 N GLN M 37 SHEET 8 MB 9 TYR M 107 PHE M 108 -1 O TYR M 107 N SER M 94 SHEET 9 MB 9 ALA M 88 SER M 95 -1 O SER M 94 N TYR M 107 SHEET 1 MC 7 LYS M 126 PHE M 130 0 SHEET 2 MC 7 LYS M 142 PHE M 152 -1 O VAL M 146 N PHE M 130 SHEET 3 MC 7 SER M 189 SER M 199 -1 O TYR M 190 N PHE M 152 SHEET 4 MC 7 VAL M 172 THR M 174 -1 O SER M 173 N ARG M 195 SHEET 5 MC 7 SER M 189 SER M 199 -1 O ARG M 195 N SER M 173 SHEET 6 MC 7 TYR M 179 SER M 182 -1 O TYR M 179 N ALA M 191 SHEET 7 MC 7 SER M 189 SER M 199 -1 O SER M 189 N SER M 182 SHEET 1 MD 4 LYS M 166 VAL M 168 0 SHEET 2 MD 4 VAL M 157 VAL M 163 -1 O TRP M 161 N VAL M 168 SHEET 3 MD 4 HIS M 209 PHE M 216 -1 O ARG M 211 N TRP M 162 SHEET 4 MD 4 GLN M 235 TRP M 242 -1 O GLN M 235 N PHE M 216 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS E 22 CYS E 90 1555 1555 2.03 SSBOND 5 CYS E 141 CYS E 191 1555 1555 2.04 SSBOND 6 CYS F 23 CYS F 92 1555 1555 2.03 SSBOND 7 CYS F 147 CYS F 212 1555 1555 2.03 SSBOND 8 CYS H 101 CYS H 164 1555 1555 2.04 SSBOND 9 CYS H 203 CYS H 259 1555 1555 2.03 SSBOND 10 CYS I 25 CYS I 80 1555 1555 2.03 SSBOND 11 CYS L 22 CYS L 90 1555 1555 2.03 SSBOND 12 CYS L 141 CYS L 191 1555 1555 2.04 SSBOND 13 CYS M 23 CYS M 92 1555 1555 2.03 SSBOND 14 CYS M 147 CYS M 212 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 2.33 CISPEP 2 HIS B 31 PRO B 32 0 1.81 CISPEP 3 SER F 7 PRO F 8 0 -0.66 CISPEP 4 TYR H 209 PRO H 210 0 3.02 CISPEP 5 HIS I 31 PRO I 32 0 2.86 CISPEP 6 SER M 7 PRO M 8 0 -0.52 CISPEP 7 PHE M 153 PRO M 154 0 -0.05 CRYST1 93.422 83.893 122.273 90.00 92.21 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010704 0.000000 0.000413 0.00000 SCALE2 0.000000 0.011920 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008185 0.00000